Prescription Pricing for the People Act of 2019
Official title: A bill to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate pol… Show full official titleShow less
Official title: A bill to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 131.
Prescription Pricing for the People Act of 2019
This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescriptions drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.
- Introduced in Senate Formatted Text PDF Formatted XML
- Reported to Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 1227: Prescription Pricing for the People Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-S-1227/
"S. 1227: Prescription Pricing for the People Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-1227/.
S. 1227, 116th Cong. (2026), https://openamerica.io/bill/116-S-1227/.
[S. 1227: Prescription Pricing for the People Act of 2019](https://openamerica.io/bill/116-S-1227/)